Human FABP5/E-FABP Antibody, R&D Systems™

FABP5/E-FABP

Monoclonal

LYOPH

Western Blot 1 μg/mL, Flow Cytometry 0.25 ug/10^6 cells, Immunocytochemistry 8-25 μg/mL, CyTOF-ready, Knockout Validated

Q01469

FABP5

E. coli-derived recombinant human FABP5/E-FABP Ala2-Glu135 Accession # Q01469

100 μg

Primary

Detects human FABP5/E-FABP in direct ELISAs and Western blots. In direct ELISAs and Western blots, no cross-reactivity with recombinant human FABP1, 2, 3, 4, 6, 7, or 9 is observed.

Human

Purified

Western Blot, Flow Cytometry, Immunocytochemistry, CyTOF, Immunoassay

311215

Unconjugated

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative

EFABP, E-FABP, E-FABPPAFABP, fatty acid binding protein 5 (psoriasis-associated), Fatty acid-binding protein 5, PA-FABPepidermal, Psoriasis-associated fatty acid-binding protein homolog

Rat

Protein A or G purified from hybridoma culture supernatant

RUO

2171

Reconstitute at 0.5 mg/mL in sterile PBS.

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.

IgG2a